Relmada Therapeutics
Earnings Surprise
Analysts estimated RLMD earnings of $-0.14 per share this quarter (Q4). RLMD's actual earnings were $-0.29 per share.
RLMD EPS surprise of -103.08%Analysts estimated RLMD earnings of $-0.12 per share this quarter (Q3). RLMD's actual earnings were $-0.30 per share.
RLMD EPS surprise of -153.59%Analysts estimated RLMD earnings of $-0.26 per share this quarter (Q2). RLMD's actual earnings were $-0.30 per share.
RLMD EPS surprise of -17.65%Analysts estimated RLMD earnings of $-0.32 per share this quarter (Q1). RLMD's actual earnings were $-0.58 per share.
RLMD EPS surprise of -83.43%Analysts estimated RLMD earnings of $-0.71 per share this quarter (Q4). RLMD's actual earnings were $-0.62 per share.
RLMD EPS surprise of 12.98%Analysts estimated RLMD earnings of $-0.65 per share this quarter (Q3). RLMD's actual earnings were $-0.72 per share.
RLMD EPS surprise of -10.13%Analysts estimated RLMD earnings of $-0.84 per share this quarter (Q2). RLMD's actual earnings were $-0.59 per share.
RLMD EPS surprise of 30.01%Analysts estimated RLMD earnings of $-0.87 per share this quarter (Q1). RLMD's actual earnings were $-0.72 per share.
RLMD EPS surprise of 16.90%Analysts estimated RLMD earnings of $-0.93 per share this quarter (Q3). RLMD's actual earnings were $-0.73 per share.
RLMD EPS surprise of -21.61%